WEDGE CAPITAL MANAGEMENT L L P/NC

Position in TBPH — Theravance Biopharma, Inc.

CIK 1015308 CHARLOTTE, NC

Position in TBPH

as of Jun 30, 2026 · filed Jul 10, 2026 Compact

Position Value

$2,190,365

New position

Shares Held

128,845

first reported quarter

Ownership

0.250%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

of 8 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 32.69820326749195.ToString("F0")% Shared 0.ToString("F0")% None 67.30179673250805.ToString("F0")%

Healthcare · as of Jun 30, 2026

WEDGE CAPITAL MANAGEMENT L L P/NC holds $146,192,500 across 9 Biotechnology names. TBPH ranks #7 (1.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	770,422	$43,197,561
2	HALO	Halozyme Therapeutics, Inc.	403,824	$31,607,304
3	JAZZ	Jazz Pharmaceuticals plc	126,539	$30,492,102
4	REGN	Regeneron Pharmaceuticals, Inc.	47,775	$29,789,623
5	HRMY	Harmony Biosciences Holdings, Inc.	82,530	$3,004,917
6	RYTM	Rhythm Pharmaceuticals, Inc.	23,422	$2,600,544
7	TBPH	Theravance Biopharma, Inc. This page	128,845	$2,190,365
8	SVRA	Savara Inc	294,215	$1,812,364

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,190,365	128,845	—	Shares	Sole	2026-07-10
No filing history on record for this holder in this stock.